• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Chinese population study shows high prevalence of elevated cardiovascular disease risk and low utilization of pharmacotherapy

byKathleen W. HigginsandDeepti Shroff
February 21, 2019
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors
Share on FacebookShare on TwitterShare on LinkedIn

1. In this national screening project, around 10% of middle-aged Chinese subjects were found to be at “high risk” for cardiovascular disease.

2. Aspirin and statins were only used by 0.6% and 2.4% of high-risk individuals, respectively.

Evidence Rating Level: 3 (Average)

Study Rundown: A 2015 study showed that cardiovascular disease (CVD) is now the leading cause of death in China, accounting for 40% of all deaths.  This statistic is likely to rise further, given the country’s rapidly aging population and increasing rates of risk factors like diabetes, hypertension, and smoking.  This study was the result of a national screening effort to understand the prevalence of CVD in Chinese adults and to identify modifiable risk factors that can be targeted in future health programs.  Of the 1.7 million adults surveyed, 9.5% met criteria for being at “high risk” for cardiovascular disease.  Common modifiable risk factors included hypertension, dyslipidemia, diabetes, smoking, and alcohol.  However, only a small fraction of high risk adults received aspirin, statins, or antihypertensive medication. Compared to previous studies, this study covered a considerably larger cross section of the Chinese population, including patients from all 31 provinces of the country.  However, it relied upon a “convenience sampling strategy,” which raises concerns for sampling bias.  It is also important to note that definition of CVD risk was determined by international organizations, and has not been validated for the Chinese population

Click to read the study in Annals of Internal Medicine

Click to read the accompanying editorial in Annals of Internal Medicine

RELATED REPORTS

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

Relevant Reading: China cardiovascular diseases report 2015: a summary

In-Depth [cross-sectional study]: This study evaluated the prevalence and risk factors for CVD in a population of 1.7 million Chinese adults from across China.  Patients were selected by convenience, and were omitted from analysis if they had pre-existing CVD or if their data were not complete.  The authors used a risk prediction algorithm developed by the World Health Organization and the International Society for Hypertension, which take into account age, sex, smoking, systolic blood pressure, diabetes, and total cholesterol.  Demographic factors associated with high CVD risk included Han ethnicity, current alcohol use, and insurance status.  Having a higher education, being married, or working as a farmer were associated with decreased risk.  Among patients identified as “high risk,” around 96.2% had co-morbid hypertension, 54.9% had diabetes, 29.7% smoked, and 18.1% drank alcohol.  Notably, only about 43.1% of patients with hypertension and 30.6% of patients were aware of their diagnosis.   When all different subpopulations were pooled, only 0.5% of high risk patients were taking statins (CI95: 0.5% to 0.6%) and only 2.4% were taking aspirin (CI95 2.3% to 2.5%).  In certain subgroups, these rates were as high as 4% and 6%, respectively.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular disease
Previous Post

The KATHERINE trial: trastuzumab emtansine more effective than trastuzumab alone for treating residual HER2-positive breast cancer

Next Post

Quick Take: Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics

RelatedReports

Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

September 3, 2026
Jessica Lau
Psychiatry

WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

September 4, 2026
Reduced gestational weight gain with lifestyle intervention
Cardiology

Replacing sedentary time with physical activity may lower risk of all-cause mortality

March 2, 2026
Next Post
Quick Take: Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics

Quick Take: Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics

Herpes zoster vaccine not cost-effective for 50 year-old adults

New herpes zoster vaccine predicted to be more cost effective than predecessor  

2 Minute Medicine Rewind February 18, 2019

Quick Take: Association between Periprocedural Neutropenia and Early Infection-related Chest Port Removal

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind October 19, 2026
  • Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography
  • Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.